Physician profile
Christopher E Ramsey
NPI 1205836343
$5,736.75
in general payments reported to CMS, 2019-2025
39 companies · $716 in 2025
The $716 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $973 · 2020: $365 · 2021: $714 · 2022: $1,309 · 2023: $619 · 2024: $1,040 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Travel and Lodging: $19.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,856.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Travel and Lodging | $19.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,881.41 | 2019-2024 | Da Vinci Surgical System |
| Amgen INC. | $274.82 | 2019-2021 | |
| Astellas Pharma US INC | $267.96 | 2019-2025 | Xtandi |
| C. R. Bard, INC. & Subsidiaries | $239.77 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Sumitomo Pharma America, INC. | $220.74 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $211.67 | 2019-2024 | Spaceoar Vue System - 10ml |
| Bayer Healthcare Pharmaceuticals INC. | $157.59 | 2022-2023 | |
| Pfizer INC. | $143.56 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $130.36 | 2022-2025 | Keytruda |
| Abbvie INC. | $113.63 | 2019-2025 | |
| Janssen Biotech, INC. | $100.95 | 2019-2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $97.04 | 2021-2025 | Prolaris |
| Procept Biorobotics Corporation | $80.33 | 2024 | Aquabeam System |
| Urogen Pharma, INC. | $77.58 | 2023-2025 | Jelmyto |
| Antares Pharma, INC. | $71.01 | 2019-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ramsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.